Based on the work of the TCGA network, multidimensional genomic data have been integrated to classify GBM into proneural, neural, classical, and mesenchymal subtypes based on the aberrations and gene expression of EGFR, NF1, and PDGFRA/IDH1. The gene discussed is EGFR; the disease is glioblastoma.